Murillo, H <br/><br/>
Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state.  [electronic resource] 

 -  Endocrinology  Nov 2001 
 - 4795-805 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0013-7227 
<br/><br/><label>Standard No.: </label>10.1210/endo.142.11.8467  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--pharmacology<br/>Androgens--physiology<br/>Cell Cycle Proteins--metabolism<br/>Cell Division--physiology<br/>Cell Survival--physiology<br/>Chromones--pharmacology<br/>Culture Media--pharmacology<br/>Cyclin-Dependent Kinase Inhibitor p27<br/>Disease Progression<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Male<br/>Morpholines--pharmacology<br/>Phosphatidylinositol 3-Kinases--physiology<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Prostatic Neoplasms--physiopathology<br/>Protein Serine-Threonine Kinases<br/>Proto-Oncogene Proteins--physiology<br/>Proto-Oncogene Proteins c-akt<br/>Signal Transduction--physiology<br/>Tumor Cells, Cultured<br/>Tumor Suppressor Proteins--metabolism